PPAR inhibitors
PPAR (peroxisome proliferator-activated receptor) inhibitors are substances that block the activation or function of PPARs, a group of nuclear receptor proteins that play crucial roles in regulating metabolic processes, inflammation, and cell differentiation. PPARs act as ligand-activated transcription factors that modulate gene expression in response to ligand binding, such as fatty acids and their derivatives. By inhibiting PPAR activity, these inhibitors can affect lipid metabolism, glucose homeostasis, and inflammatory pathways. PPAR inhibitors are studied for their potential therapeutic applications in diseases like diabetes, cardiovascular disorders, and inflammatory conditions where PPAR dysregulation contributes to disease progression. Research aims to develop selective PPAR inhibitors that can target specific PPAR isoforms (α, β/δ, γ) to modulate metabolic pathways effectively while minimizing adverse effects, thus offering new therapeutic strategies for managing metabolic and inflammatory diseases.
- Structure
- Product name
- CAS No.
- Molecular formula
- Inquiry
Total:1 Page 1 of 1 1
